Trump seeks to cut drug prices via executive order
The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts


What happened
President Donald Trump Monday signed an executive order aimed at persuading pharmaceutical companies to lower the prices of U.S. prescription drugs. Trump's order gives companies a 30-day deadline to start voluntarily lowering prices or face potential consequences.
Who said what
The White House "teased the announcement as seismic," but Trump's order lacks "teeth" and "cites no obvious legal authority to mandate lower prices," The New York Times said. It was "something of a win" for drugmakers, which had been "bracing" for a "much more damaging" policy. "Far from demonizing pharmaceutical companies for high prices," The Washington Post said, Trump "focused his fire" on European countries "for negotiating drug prices so low" the U.S. picks up the "costs of innovation."
Sen. Bernie Sanders (I-Vt.) said while he agreed with Trump that U.S. drug prices are "an outrage," the problem was not that prices are "too low in Europe and Canada" but that the "extraordinarily greedy pharmaceutical industry" is "ripping off the American people." Besides, he added, "as Trump well knows, his executive order will be thrown out by the courts."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What next?
If drug companies do not lower their prices, Trump's order directs Health Secretary Robert F. Kennedy Jr. to develop a new rule that "ties the price the U.S. pays for medications to lower prices paid by other countries," said The Associated Press.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
What are VPNs and how do they work?
The Explainer UK sees surge in use of virtual private networks after age verification comes into effect for online adult content
-
Why is it so hard to find an 'eligible' man?
In the Spotlight The lack of college-educated suitors is forcing women to 'marry down'
-
Quiz of The Week: 26 July – 1 August
Have you been paying attention to The Week's news?
-
Why the FDA wants to restrict kratom-related products
In the Spotlight The compound is currently sold across the United States
-
Food may contribute more to obesity than exercise
Under the radar The devil's in the diet
-
Not just a number: how aging rates vary by country
The explainer Inequality is a key factor
-
Scientists have identified 4 distinct autism subtypes
Under the radar They could lead to more accurate diagnosis and care
-
Children's health has declined in the US
The Explainer It's likely a sign of larger systemic issues
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
A disproven medical theory could be guiding RFK Jr.'s health policy
The Explainer The miasma theory is one of the oldest medical beliefs in history